Trial Profile
Pharmacokinetic Study of ABT-126 in Healthy Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Nov 2010
Price :
$35
*
At a glance
- Drugs Nelonicline (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions; Pharmacokinetics
- 13 Oct 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 26 Aug 2009 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 19 Aug 2009 New trial record